Protara Therapeutics, Inc. (TARA)
3.88
+0.03
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
3.88
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Total Liabilities (Quarterly) : 14.78M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.78M |
| March 31, 2026 | 10.72M |
| December 31, 2025 | 13.06M |
| September 30, 2025 | 12.34M |
| June 30, 2025 | 12.51M |
| March 31, 2025 | 10.08M |
| December 31, 2024 | 14.32M |
| September 30, 2024 | 12.30M |
| June 30, 2024 | 9.597M |
| March 31, 2024 | 9.728M |
| December 31, 2023 | 10.63M |
| September 30, 2023 | 11.51M |
| June 30, 2023 | 9.916M |
| March 31, 2023 | 11.64M |
| December 31, 2022 | 11.21M |
| September 30, 2022 | 9.413M |
| June 30, 2022 | 9.426M |
| March 31, 2022 | 9.021M |
| December 31, 2021 | 10.68M |
| September 30, 2021 | 10.29M |
| June 30, 2021 | 10.49M |
| March 31, 2021 | 4.287M |
| December 31, 2020 | 3.914M |
| September 30, 2020 | 4.282M |
| June 30, 2020 | 3.825M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.354M |
| December 31, 2019 | 3.351M |
| September 30, 2019 | 1.613M |
| June 30, 2019 | 2.123M |
| March 31, 2019 | 3.37M |
| December 31, 2018 | 3.078M |
| September 30, 2018 | 2.534M |
| June 30, 2018 | 2.231M |
| March 31, 2018 | 9.02M |
| December 31, 2017 | 9.24M |
| September 30, 2017 | 9.094M |
| June 30, 2017 | 4.137M |
| March 31, 2017 | 3.023M |
| December 31, 2016 | 5.079M |
| September 30, 2016 | 4.875M |
| June 30, 2016 | 4.738M |
| March 31, 2016 | 3.588M |
| December 31, 2015 | 4.133M |
| September 30, 2015 | 3.252M |
| June 30, 2015 | 2.816M |
| March 31, 2015 | 2.634M |
| December 31, 2014 | 2.338M |
| September 30, 2014 | 14.56M |
| June 30, 2014 | 12.53M |
| March 31, 2014 | 10.97M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NovelStem International Corp. | 2.097M |
| Brainstorm Cell Therapeutics, Inc. | 12.38M |
| Summit Therapeutics, Inc. | 122.20M |
| Kezar Life Sciences, Inc. | 2.762M |
| Clene, Inc. | 47.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 176.09M |
| Shareholders Equity (Quarterly) | 161.31M |
| Debt to Equity Ratio | 0.017 |
| Current Ratio | 10.97 |
| Net Debt Paydown Yield | 0.13% |